< Back to Article

MK-8527 is a novel inhibitor of HIV-1 reverse transcriptase translocation with potential for extended-duration dosing

Table 2

Pharmacokinetics of MK-8527 in plasma from rats and monkeys.

doi: https://doi.org/10.1371/journal.pbio.3003308.t002